249 related articles for article (PubMed ID: 2093531)
1. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
Baldamus CA; Steffen AM; Brunner R; Pollok M
Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
[No Abstract] [Full Text] [Related]
2. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
Schaefer RM; Heidland A
Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
[No Abstract] [Full Text] [Related]
3. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
Schaefer RM; Leschke M; Strauer BE; Heidland A
Am J Nephrol; 1988; 8(6):449-53. PubMed ID: 3218658
[TBL] [Abstract][Full Text] [Related]
4. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
[TBL] [Abstract][Full Text] [Related]
5. [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
Massetani R; Galli R; Calabrese R; Sartucci F; Rindi P; Severino Brandi L; Murri L
Riv Neurol; 1991; 61(6):215-8. PubMed ID: 1813973
[TBL] [Abstract][Full Text] [Related]
6. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
[No Abstract] [Full Text] [Related]
7. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
Koppensteiner R; Stockenhuber F; Jahn C; Balcke P; Minar E; Ehringer H
BMJ; 1990 Jun; 300(6740):1626-7. PubMed ID: 2372642
[No Abstract] [Full Text] [Related]
8. [Treatment of anemia in chronically dialyzed patients].
Moynot A
Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
[No Abstract] [Full Text] [Related]
9. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
[TBL] [Abstract][Full Text] [Related]
10. The treatment of anemia with low-dose recombinant human erythropoietin.
Aronoff GR; Duff DR; Sloan RS; Brier ME; Maurice B; Erickson B; Golper TA
Am J Nephrol; 1990; 10 Suppl 2():40-3. PubMed ID: 2260617
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
Tomura S
Nihon Rinsho; 1991 Dec; 49 Suppl():695-701. PubMed ID: 1808338
[No Abstract] [Full Text] [Related]
12. Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group.
Am J Nephrol; 1991; 11(1):23-6. PubMed ID: 2048574
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H
Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
[No Abstract] [Full Text] [Related]
14. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.
Shand BI; Buttimore AL; Lynn KL; Bailey RR; Robson RA
Ren Fail; 1994; 16(3):407-13. PubMed ID: 8059023
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin.
Haberl M
Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
[No Abstract] [Full Text] [Related]
16. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
[No Abstract] [Full Text] [Related]
17. Impact of erythropoietin on the dialysis prescription.
Van Wyck DB
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
[TBL] [Abstract][Full Text] [Related]
18. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
Carlini R; Obialo CI; Rothstein M
Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
[TBL] [Abstract][Full Text] [Related]
19. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
20. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy.
Raine AE
Lancet; 1988 Jan; 1(8577):97-100. PubMed ID: 2891990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
